This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Esocap Ag, Universität Greifswald. Active years: 2020-2025.
Company Filing History:
Years Active: 2020-2025
Title: Michael Grimm: Innovator in Pharmaceutical Dosage Forms
Introduction
Michael Grimm is a notable inventor based in Greifswald, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms for mucous membranes. With a total of 2 patents to his name, his work is recognized for its potential to enhance drug delivery methods.
Latest Patents
Grimm's latest patents focus on pharmaceutical dosage forms designed for application to mucous membranes. These inventions include a sheet-like preparation, which can be film-shaped, foil-shaped, or wafer-shaped, containing an active pharmaceutical ingredient. The unique aspect of his inventions is the incorporation of a release mechanism and a trigger mechanism. This trigger mechanism is specifically designed to activate the release of the preparation at predetermined sites within the gastrointestinal tract, rectum, or vagina, thereby improving the efficacy of the medication.
Career Highlights
Throughout his career, Michael Grimm has worked with various organizations, including Esocap AG and Universität Greifswald. His experience in these institutions has allowed him to refine his expertise in pharmaceutical sciences and contribute to innovative research.
Collaborations
Some of his notable coworkers include Kirsten Kirsch and Mirko Koziolek. Their collaborative efforts have likely played a role in advancing the research and development of pharmaceutical technologies.
Conclusion
Michael Grimm's contributions to the field of pharmaceuticals, particularly through his innovative dosage forms, highlight his role as a significant inventor. His work continues to influence the way medications are delivered, showcasing the importance of innovation in healthcare.